10 B34.2 Infection due to coronaviruses of unspecified location 10 J12.9 Viral pneumonia, unspecified 10 N39.0 Urinary tract infection, localization unspecified 10 O99.5 Diseases of the respiratory system complicating pregnancy, childbirth, and puer- perium 10 R06.0 Dyspnea 10 R53 Unwellness and ...
Comorbidities were identified using the International Classification of Diseases 10th Revision (ICD-10) and were collected during 12 months before the index date (Supplementary Table S1). Comorbid conditions included those associated with an increased risk of severe COVID-19 disease according to the ...
19 treatment in the Czech Republic during the study period. Further complicating any attempt at comparative effectiveness is the positioning between nirmatrelvir/ritonavir and MOV in COVID-19 treatment guidelines. Channeling bias may result where MOV is generally prescribed to more medically complex ...
19 treatment in the Czech Republic during the study period. Further complicating any attempt at comparative effectiveness is the positioning between nirmatrelvir/ritonavir and MOV in COVID-19 treatment guidelines. Channeling bias may result where MOV is generally prescribed to more medically complex ...